SPHRY
Price
$0.64
Change
+$0.05 (+8.47%)
Updated
Jul 3 closing price
Capitalization
25.03M
44 days until earnings call
VBIZF
Price
$0.20
Change
-$0.04 (-16.67%)
Updated
Jul 1 closing price
Capitalization
385.1M
Interact to see
Advertisement

SPHRY vs VBIZF

Header iconSPHRY vs VBIZF Comparison
Open Charts SPHRY vs VBIZFBanner chart's image
Starpharma Holdings
Price$0.64
Change+$0.05 (+8.47%)
Volume$500
Capitalization25.03M
Viva Biotech Holdings
Price$0.20
Change-$0.04 (-16.67%)
Volume$3K
Capitalization385.1M
SPHRY vs VBIZF Comparison Chart in %
Loading...
SPHRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SPHRY vs. VBIZF commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPHRY is a Hold and VBIZF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 08, 2025
Stock price -- (SPHRY: $0.64 vs. VBIZF: $0.20)
Brand notoriety: SPHRY and VBIZF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SPHRY: 78% vs. VBIZF: 111%
Market capitalization -- SPHRY: $25.03M vs. VBIZF: $385.1M
SPHRY [@Biotechnology] is valued at $25.03M. VBIZF’s [@Biotechnology] market capitalization is $385.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SPHRY’s FA Score shows that 1 FA rating(s) are green whileVBIZF’s FA Score has 1 green FA rating(s).

  • SPHRY’s FA Score: 1 green, 4 red.
  • VBIZF’s FA Score: 1 green, 4 red.
According to our system of comparison, both SPHRY and VBIZF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SPHRY’s TA Score shows that 6 TA indicator(s) are bullish while VBIZF’s TA Score has 3 bullish TA indicator(s).

  • SPHRY’s TA Score: 6 bullish, 2 bearish.
  • VBIZF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SPHRY is a better buy in the short-term than VBIZF.

Price Growth

SPHRY (@Biotechnology) experienced а +11.29% price change this week, while VBIZF (@Biotechnology) price change was -18.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.35%. For the same industry, the average monthly price growth was +13.82%, and the average quarterly price growth was -0.82%.

Reported Earning Dates

SPHRY is expected to report earnings on Aug 20, 2025.

Industries' Descriptions

@Biotechnology (+5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VBIZF($385M) has a higher market cap than SPHRY($25M). VBIZF YTD gains are higher at: 179.267 vs. SPHRY (-0.651).
SPHRYVBIZFSPHRY / VBIZF
Capitalization25M385M6%
EBITDA-13.7MN/A-
Gain YTD-0.651179.267-0%
P/E RatioN/A23.65-
Revenue2.98MN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SPHRY: Fundamental Ratings
SPHRY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SPHRYVBIZF
RSI
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
59%
Bullish Trend 5 days ago
61%
Momentum
ODDS (%)
Bullish Trend 5 days ago
60%
Bearish Trend 5 days ago
72%
MACD
ODDS (%)
Bullish Trend 5 days ago
60%
Bearish Trend 5 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
60%
Bearish Trend 5 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
50%
Bearish Trend 5 days ago
58%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
89%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
41%
Bullish Trend 5 days ago
19%
View a ticker or compare two or three
Interact to see
Advertisement
SPHRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GBUX2.250.57
+33.75%
GIVBUX INC.
FCNCB1800.009.99
+0.56%
First Citizens BancShares, Inc.
EUSHY2.90N/A
N/A
Eurocash SA
HKUOY15.90N/A
N/A
Hakuhodo Dy Holdings, Inc.
MCRAA48.20N/A
N/A
McRae Industries, Inc.

SPHRY and

Correlation & Price change

A.I.dvisor tells us that SPHRY and VACBF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPHRY and VACBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHRY
1D Price
Change %
SPHRY100%
+8.88%
VACBF - SPHRY
26%
Poorly correlated
N/A
SPHRF - SPHRY
26%
Poorly correlated
N/A
REVB - SPHRY
23%
Poorly correlated
-1.31%
ZBIO - SPHRY
22%
Poorly correlated
-1.86%
TTNP - SPHRY
22%
Poorly correlated
+1.15%
More

VBIZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VBIZF has been loosely correlated with CLDI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if VBIZF jumps, then CLDI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIZF
1D Price
Change %
VBIZF100%
N/A
CLDI - VBIZF
34%
Loosely correlated
+5.09%
SPHRY - VBIZF
11%
Poorly correlated
+8.88%
WXXWY - VBIZF
3%
Poorly correlated
+0.08%
UCBJF - VBIZF
3%
Poorly correlated
-0.03%
ZLDAF - VBIZF
2%
Poorly correlated
N/A
More